Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis

Chest

Volumn 144, Issue 4, 2013, Pages 1186-1192

  Farhat, Sylvia C L ^a   Almeida, Marina B ^b   Silva Filho, Luiz Vicente R F ^a,b   Farhat, Juliana ^a   Rodrigues, Joaquim C ^b   Braga, Alfésio L F ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Clinics Hospital   (Brazil)

^c CATHOLIC UNIVERSITY OF SANTOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885143991     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2414     Document Type: Article

References (45)

1. Bell ML, Dominici F, Samet JM. A meta-analysis of time-series studies of ozone and mortality with comparison to the national morbidity, mortality, and air pollution study. Epidemiology. 2005; 16 (4): 436-445.
2. Delfino RJ, Gillen DL, Tjoa T, et al. Electrocardiographic ST-segment depression and exposure to traffic-related aerosols in elderly subjects with coronary artery disease. Environ Health Perspect. 2011; 119 (2): 196-202.
3. Hůnová I, Malý M, Rezáčová J, Braniš M. Association between ambient ozone and health outcomes in Prague. Int Arch Occup Environ Health. 2013 ;86(1): 89-97.
4. Fraga J, Botelho A, Sá A, Costa M, Quaresma M. The lag structure and the general effect of ozone exposure on pediatric respiratory morbidity. Int J Environ Res Public Health. 2011; 8 (10): 4013-4024.
5. Brook RD, Rajagopalan S, Pope CA III, et al; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010; 121 (21): 2331-2378.
6. Lin CA, Amador Pereira LA, de Souza Conceição GM, et al. Association between air pollution and ischemic cardiovascular emergency room visits. Environ Res. 2003; 92 (1): 57-63.
7. Farhat SC, Paulo RL, Shimoda TM, et al. Effect of air pollution on pediatric respiratory emergency room visits and hospital admissions. Braz J Med Biol Res. 2005; 38 (2): 227-235.
8. Santos UP, Terra-Filho M, Lin CA, et al. Cardiac arrhythmia emergency room visits and environmental air pollution in Sao Paulo, Brazil. J Epidemiol Community Health. 2008; 62 (3): 267-272.
9. Olmo NR, Saldiva PH, Braga AL, Lin CA, Santos U de P, Pereira LA. A review of low-level air pollution and adverse effects on human health: implications for epidemiological studies and public policy. Clinics (Sao Paulo). 2011; 66(4): 681-690.
10. Ratjen F, Döring G. Cystic fibrosis. Lancet. 2003; 361 (9358): 681-689.
11. da Silva Filho LV, Zerbinati RM, Tateno AF, et al. The differential clinical impact of human coronavirus species in children with cystic fibrosis. J Infect Dis. 2012; 206 (3): 384-388.
12. de Almeida MB, Zerbinati RM, Tateno AF, et al. Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis. 2010; 16 (6): 996-999.
13. Dakin CJ, Numa AH, Wang H, Morton JR, Vertzyas CC, Henry RL. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med. 2002; 165 (7): 904-910.
14. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995; 151 (4): 1075-1082.
15. Rottner M, Freyssinet JM, Martínez MC. Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir Res. 2009; 10: 23.
16. Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res. 2006; 7: 138 10.1186/1465-9921-7-138.
17. Schechter MS. Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med. 2011; 17 (6): 448-454.
18. Polgar G, Weng TR. The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis. 1979; 120 (3): 625-695.
19. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5): 948-968.
20. Bateson TF, Schwartz J. Children's response to air pollutants. J Toxicol Environ Health A. 2008; 71 (3): 238-243.
21. Grigg J. Particulate matter exposure in children: relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009; 6 (7): 564-569.
22. Kamdar O, Le W, Zhang J, Ghio AJ, Rosen GD, Upadhyay D. Air pollution induces enhanced mitochondrial oxidative stress in cystic fibrosis airway epithelium. FEBS Lett. 2008; 582 (25-26): 3601-3606.
23. Cystic Fibrosis Foundation Patient Registry. 2009 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2011.
24. Britto MT, Kotagal UR, Hornung RW, Atherton HD, Tsevat J, Wilmott RW. Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis. Chest. 2002; 121 (1): 64-72.
25. Sanders DB, Bittner RC, Rosenfeld M et al. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011; 46 (4): 393-400.
26. de Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011; 66 (8): 680-685.
27. Dockery DW, Cunningham J, Damokosh AI, et al. Health effects of acid aerosols on North American children: respiratory symptoms. Environ Health Perspect. 1996; 104 (5): 500-505.
28. Liu L, Poon R, Chen L, et al. Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. Environ Health Perspect. 2009; 117(4): 668-674.
29. Strickland MJ, Darrow LA, Klein M, et al. Short-term associations between ambient air pollutants and pediatric asthma emergency department visits. Am J Respir Crit Care Med. 2010; 182 (3): 307-316.
30. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004; 169 (7): 816-821.
31. Jassal MS, Yu AM, Bhatia R, Keens TG, Davidson Ward SL. Effect of residential proximity to major roadways on cystic fibrosis exacerbations. Int J Environ Health Res. 2013; 23 (2): 119-131. 10.1080/09603123.2012.708917.
32. World Health Organization. Air quality guidelines. Global update 2005.Particulate matter, ozone, nitrogen dioxide and sulfur dioxide. Cap 7.2 ozone. WHO website. http://www.euro.who.int/en/what-we-publish/abstracts/air- qualityguidelines.- global-update-2005.-particulate-matter,-ozone,- nitrogen-dioxide-and-sulfur-dioxide. Accessed May 27, 2012.
33. CETESB. Rede de Monitoramento. CETESB website. http://sistemasinter. cetesb.sp.gov.br/ar/ar-automatica.asp. Accessed February 2012.
34. Sérgio Chiarelli P, Amador Pereira LA, Nascimento Saldiva PH, et al. The association between air pollution and blood pressure in traffic controllers in Santo André, São Paulo, Brazil. Environ Res. 2011; 111 (5): 650-655.
35. Sarnat SE, Coull BA, Schwartz J, Gold DR, Suh HH. Factors affecting the association between ambient concentrations and personal exposures to particles and gases. Environ Health Perspect. 2006; 114 (5): 649-654.
36. Rojas-Bracho L, Suh HH, Catalano PJ, Koutrakis P. Personal exposures to particles and their relationships with personal activities for chronic obstructive pulmonary disease patients living in Boston. J Air Waste Manag Assoc. 2004; 54(2): 207-217.
37. Song S, Wu Y, Jiang J, Yang L, Cheng Y, Hao J. Chemical characteristics of size-resolved PM 2.5 at a roadside environment in Beijing, China. Environ Pollut. 2012; 161: 215-221.
38. Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000; 21 (1-2): 1-48.
39. Valavanidis A, Fiotakis K, Vlachogianni T. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008; 26 (4): 339-362.
40. Kosmider B, Loader JE, Murphy RC, Mason RJ. Apoptosis induced by ozone and oxysterols in human alveolar epithelial cells. Free Radic Biol Med. 2010; 48 (11): 1513-1524.
41. Beydon N, Amsallem F, Bellet M, et al. Pulmonary function tests in preschool children with cystic fibrosis. Am J Respir Crit Care Med. 2002; 166 (8): 1099-1104.
42. Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med. 1990; 323 (12): 782-788.
43. Smyth A, O'Hea U, Williams G, Smyth R, Heaf D. Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child. 1994; 71 (4): 353-354.
44. Smyth A, O'Hea U, Feyerabend C, Lewis S, Smyth R. Trends in passive smoking in cystic fibrosis, 1993-1998. Pediatr Pulmonol. 2001; 31 (2): 133-137.
45. Collaco JM, Vanscoy L, Bremer L, et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA. 2008; 299 (4): 417-424.